Medulloblastoma with myogenic differentiation: Long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation
- William Rattenberry,
- ,
- Peter C. Burger,
- Kenneth J. Cohen(corresponding author)
- University of Oxford,
- ,
- Johns Hopkins University
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewSustainable Development Goals
SDG 3 Good Health and Well
Abstract
Medulloblastoma with myogenic differentiation (MMD) is a rare and aggressive variant of medulloblastoma, occurring predominantly in children. There have been only two case reports of long-term survival previously published. We report a case of long-term disease-free survival in a 21-year-old diagnosed with MMD.
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 659-662 (4 pages)Journal (Volume, Issue Number)
Journal of Neuro-Oncology (Volume 105, Issue 3)Publication milestones
- Published - 12/2011
Publication status
Published - 12/2011
ISSN
0167-594XPublication IDs
- Scopus: 82955203397
- PubMed: 21688181
Publication metrics
Metrics
SciVal
Author count
4
SciVal
citations
3
SciVal
Paper percentile
45
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
12
Citation count
3
Funding Details
FunderFunding number
NCI
P30CA006973